Stephen From - Jan 5, 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Executive Chairman, Director
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Jan 5, 2022
Transactions value $
-$352
Form type
4
Date filed
1/6/2022, 04:10 PM
Previous filing
Dec 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$352 -326 -0.48% $1.08 67.7K Jan 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022.